UTokyo medical-engineering startup developing home glycoalbumin testing devices and diabetes app
| Date | Round | Amount |
|---|---|---|
| Oct 2024 | Funding round Provigate, a diabetes-monitoring medical-device developer, raised about 2B JPY combining an 830M JPY equity round (new investor Sysmex; existing Ain, Sparx, Toyoda Gosei, JST) and a 1.2B JPY NEDO deep-tech grant. | $13M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.